ANI Pharmaceuticals ($ANIP) Insider Trading & Smart Money Activity
ANI Pharmaceuticals, Inc. ($ANIP) has 5 insider trades and 5 13F position changes on file. In the last 12 months on the open market, no insider bought and 5 insiders sold ($913.81K), net -$913.81K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 5
- Net insider $ (12 mo)
- -$913.81K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 5
- Analyst ratings on file
- 0
ANIP insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 2 · $280.76K | 0 / 0 | 2 / 3 |
| Q3 2026 | 0 | 1 · $208.05K | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 2 · $425K | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All ANIP insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Nikhil LalwaniPRESIDENT & CEO | Sell (Open-market sale) 10b5-1 | 5.40K sh | $388.21K | -1.59% | SEC | Read | ||||
| Insider | Cook MeredithSR. VP, GENERAL COUNSEL & SEC. | Sell (Open-market sale) 10b5-1 | 500 sh | $36.80K | Read | ||||||
| Insider | Carey Stephen P.SVP & CFO | Sell (Open-market sale) 10b5-1 | 2.85K sh | $208.05K | -1.5% | — | |||||
| Insider | Stephen CareySVP & CFO | Sell (Open-market sale) 10b5-1 | 2.85K sh | $239.74K | +1.1% | -2.8% | Read | ||||
| Insider | Meredith CookSR. VP, GENERAL COUNSEL & SEC. | Sell (Open-market sale) 10b5-1 | 500 sh | $41.02K | -1.3% | -0.7% | Read | ||||
| 13F | Schonfeld Strategic Advisors | Reduced | -6.38K sh | $15.57M | +6.0% | +5.5% | Read | ||||
| 13F | Caption Management | Added | +78.12K sh | $11.40M | +6.0% | +5.5% | — | ||||
| 13F | Walleye Capital | Added | +65.77K sh | $15.36M | +0.8% | +4.0% | — | ||||
| 13F | Dekabank Deutsche Girozentrale | Sold out | -23.02K sh | -5.2% | -4.5% | — | |||||
| 13F | Dekabank Deutsche Girozentrale | Sold out | -23.02K sh | -5.2% | -4.5% | — |
1W / 1M / 6M = how ANIP moved from the trade or filing date.
Insider trading in ANIP: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Nikhil Lalwani | PRESIDENT & CEO | 1 | -$388.21K | 333.69K | Oct 15, 2026 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 1 | -$36.80K | Oct 13, 2026 | |
| Carey Stephen P. | SVP & CFO | 1 | -$208.05K | Sep 29, 2026 | |
| Stephen Carey | SVP & CFO | 1 | -$239.74K | Jun 29, 2026 | |
| Meredith Cook | SR. VP, GENERAL COUNSEL & SEC. | 1 | -$41.02K | Jun 12, 2026 |
Institutions moving ANIP (13F)
Frequently asked questions
Are ANIP insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 5 insiders made 5 open-market sales worth $913.81K, a net -$913.81K.
What is the latest insider trade in ANIP?
Nikhil Lalwani, PRESIDENT & CEO filed a sell (open-market sale) of 5.40K sh worth $388.21K on Oct 15, 2026.
Which institutions changed their ANIP positions?
Recent 13F filers moving the stock include Dekabank Deutsche Girozentrale, Schonfeld Strategic Advisors, Caption Management and Walleye Capital.
Other drug manufacturers - specialty & generic stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.